While awaiting the clinical results of potentially promising drugs in the treatment of Alzheimer’s disease, the Trecento AM team comments on Challenges the decision of Agnès Buzyn to change the patient care path.
« Even if the drug reassures, the challenge today is to change attitudes by ending the only drug to highlight the (…) »
Read the article by clicking here (available in French only)